We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Not our........... just your paranoid fkwit............... :()
worse than joker............? I don't know.
All the best (and, RNS's are the real news, good luck on your other investment :()
No rns it's from a website but price has bounced impressively on the back of it. Waiting for the next mug me off reply from our resident paranoid joker. what I did to p*ss you off so much I don't know but to be honest I am past caring now as its getting boring.
That must be from an RNS hun..............!
well done on your investment there............ :()
All the best (you have done really well.......... :)
Interesting, I was hoping NCYT might make a bid for DVRG but now it seems they are going to be taken over themselves. DVRG could be interest to others maybe?
A bid, hostile or agreed, now seems most likely for Novacyt, an international specialist in clinical diagnostics.
GlaxoSmithKline, AstraZeneca, ThermoFisher, Qiagen and Roche are seen as likely suitors.
GSK is regarded as the most likely buyer of Novacyt to bring fast growing diagnostics market into its revenue stream.
Novacyt’s rapid expansion and innovation capabilities puts it on the map for a takeover due to foreseeable revenue and growth prospects. Novacyt has become embedded into the NHS and DHSC networks and has some of the highest margins in the industry. Novacyt has an existing working relationship with GSK since their work together on the UK’s high-throughput lab in Cambridge in April 2020.
With GSK’s global distribution network, together they could become a major force in diagnostics and device technology since Novacyt’s recent acquisition of IT-IS.
GSK’s existing range includes pharmaceutical drugs, vaccines, consumer medication and now sports nutrition. Pharmaceutical drugs have onerous R&D costs with new drugs often taking decades to come to market, if at all. In 2019 alone, GSK spent over £4.5bn on R&D costs. Having a high margin, lower barrier-to-entry, diagnostics division, with an existing and expanding 550+ test range would help to buffer costs and increase group profitability.
Johnson & Johnson, GSK’s largest competitor has a medical device and diagnostics division which GSK lacks, and over 20% of JnJ’s revenues come from that area now. JnJ also quote diagnostics to have greater growth in future than other areas.
BDB Pitmans corporate team advised existing client Novacyt on its £12m acquisition of IT-IS International Limited, a diagnostic instrument development and manufacturing company. The acquisition strengthens Novacyt’s position in the market and supports the longer-term growth opportunity for rapid near-patient testing as well as securing significant IP and expanding the product offering and core capabilities in instrument manufacturing.
BDB Pitmans corporate partner Philip Weaver says: “BDB Pitmans is delighted to continue working with Novacyt as it looks to reinforce its strategy and take advantage of the opportunity that COVID-19 has presented the company as it addresses a drive towards rapid, decentralised testing.
“Client relationships are built on understanding their objectives and ambitions, and we’re delighted to be part of Novacyt’s growth story.”
It has to be 'BRITISHBULLS'
"Believers"............... :)
"Beginners".............?
"Burgers?"
Chesh, one word begins with B and ends in S. Haven't sold a bean but then you e=never believe a word I type anyway. Go and add "Troll Alert" to your next post you paranoid fkwit.
Chat lag is fun isn't it hun........... :()
All the best (You've obvs sold or at the very least released some funds to buy.......... ! :()
Spoke to soon there guys, back on track to hit the low 20s again by the end of next week with these daily drops. Expect too see a sell off on MWG as holders who don't want to swap to DVRG move on.
The only days off are forced weekends and public holidays for those money hungry scoundrels Mrstontx................. :()
They'll paint a picture of "here to service the market", but the reality is not as pretty............!
All the best (looking for liquidity ATM, with a non changed delayed, deletion that looks like x2 large sells for instance............. :()
Whats happening with the sp today, maybe the MM has taken a day off?